Elevance Health (NYSE:ELV – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday. A number ...
Elevance Health Inc. closed 26.44% below its 52-week high of $567.26, which the company reached on September 3rd.
Regulatory changes under Trump's administration and AI integration are key factors influencing Elevance Health's future ...
Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have been assigned an average rating of “Moderate Buy” from the ...
Artisan Partners, an investment management company, released its “Artisan Select Equity Fund” fourth quarter 2024 investor ...
Elevance said one of its health plan nurses worked with Haley for more than two years, helping her attend doctors’ and dialysis appointments and find stable housing. Another Elevance ...
Hosted on MSN2mon
Elevance Health, Inc. (ELV): Among the Cheap Healthcare Stocks to Buy Heading Into 2025According to Dr. Bruce Aylward, WHO Assistant Director ... to improve care quality for consumers. P/E Ratio: 13.62 Elevance Health, Inc. (NYSE:ELV), formerly Anthem, Inc., is a leading U.S ...
Shares of Elevance Health Inc. ELV rallied 1.02% to $396.88 Friday, on what proved to be an all-around favorable trading ...
In its fourth quarter 2024 investor letter, GreensKeeper Asset Management emphasized stocks such as Elevance Health, Inc. (NYSE:ELV) in the fourth quarter 2024 investor letter. Elevance Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback